Global Study on Pharmaceutical Excipients Market, 2015-2021
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<str<strong>on</strong>g>Global</str<strong>on</strong>g> <str<strong>on</strong>g>Study</str<strong>on</strong>g> <strong>on</strong> <strong>Pharmaceutical</strong> <strong>Excipients</strong> <strong>Market</strong>, <strong>2015</strong>-<strong>2021</strong><br />
By Regi<strong>on</strong><br />
<br />
<br />
<br />
<br />
<br />
North America<br />
Latin America<br />
Europe<br />
Asia Pacific<br />
Middle East & Africa<br />
<strong>Market</strong> History:<br />
<strong>Pharmaceutical</strong> excipients are substances other than pharmacologically active drug<br />
comp<strong>on</strong>ents, which are included in the drug manufacturing process or c<strong>on</strong>tained in a<br />
finished pharmaceutical product dosage form. They facilitate formulati<strong>on</strong> design and perform<br />
a range of functi<strong>on</strong>s such as increasing lubricity, enhancing flowability and improving<br />
compressibility, am<strong>on</strong>g other characteristics. The global market for pharmaceutical<br />
excipients has been segmented based <strong>on</strong> the source of origin or chemistry type as per U.S.<br />
pharmacopeia, i.e. plant-based, animal-based, mineral-based and synthetically derived<br />
excipients. The market has also been segmented by applicati<strong>on</strong> type and functi<strong>on</strong>ality of<br />
various excipients, and by regi<strong>on</strong>s.<br />
The global pharmaceutical excipients market is estimated to be valued at US$ 7,415.2 Mn by<br />
<strong>2021</strong> end, with various markets registering significant CAGRs during the forecast period.<br />
The growth of the global pharmaceutical excipients market is mainly driven by increasing<br />
demand for drugs that can be c<strong>on</strong>sumed orally. Ease of c<strong>on</strong>sumpti<strong>on</strong> and associated patient<br />
comfort has been pushing big drug makers to develop sustained-release dosage<br />
formulati<strong>on</strong>s. This also c<strong>on</strong>tributes to extended shelf life of oral drugs, which adds to higher<br />
revenue prospects. However, n<strong>on</strong>-availability of harm<strong>on</strong>ized quality standards for gradati<strong>on</strong><br />
of excipients and their safety evaluati<strong>on</strong> standards are some factors expected to restrain the<br />
growth of the market over the forecast period.<br />
Internati<strong>on</strong>al regulatory benchmarking for uniform good manufacturing and distributi<strong>on</strong><br />
practices for excipients, spanning regi<strong>on</strong>s, is set to define the market landscape of the<br />
Persistence <strong>Market</strong> Research 5